Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Taysha Gene Therapies (TSHA) Amortizatization of Intangibles (2022 - 2025)

Taysha Gene Therapies' Amortizatization of Intangibles history spans 4 years, with the latest figure at $312000.0 for Q3 2025.

  • For Q3 2025, Amortizatization of Intangibles rose 5.05% year-over-year to $312000.0; the TTM value through Sep 2025 reached $1.3 million, up 5.88%, while the annual FY2024 figure was $1.2 million, 2.96% up from the prior year.
  • Amortizatization of Intangibles for Q3 2025 was $312000.0 at Taysha Gene Therapies, up from $308000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $385000.0 in Q3 2022 and bottomed at $274000.0 in Q4 2023.
  • The 4-year median for Amortizatization of Intangibles is $305000.0 (2023), against an average of $311533.3.
  • The largest annual shift saw Amortizatization of Intangibles fell 20.78% in 2023 before it increased 9.85% in 2024.
  • A 4-year view of Amortizatization of Intangibles shows it stood at $284000.0 in 2022, then dropped by 3.52% to $274000.0 in 2023, then rose by 9.85% to $301000.0 in 2024, then increased by 3.65% to $312000.0 in 2025.
  • Per Business Quant, the three most recent readings for TSHA's Amortizatization of Intangibles are $312000.0 (Q3 2025), $308000.0 (Q2 2025), and $339000.0 (Q1 2025).